Fundraising FoxAcrobat Genomics
1 known investors
Find your way into Acrobat Genomics
Sign up to see every warm intro you have to Acrobat Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acrobat Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acrobat Genomics operates a closed-loop platform combining AI with laboratory experimentation to engineer proteins such as compact RNA-guided nucleases, with each cycle producing proprietary data to improve the next. The company applies its platform to develop genetic medicines for rare diseases and runs research programs in areas including neurodegeneration and interstitial lung disease.
Investors · 1
Frequently asked questions
- What does Acrobat Genomics do?
- Acrobat Genomics operates a closed-loop platform combining AI with laboratory experimentation to engineer proteins such as compact RNA-guided nucleases, with each cycle producing proprietary data to improve the next. The company applies its platform to develop genetic medicines for rare diseases and runs research programs in areas including neurodegeneration and interstitial lung disease.
- Who are Acrobat Genomics's investors?
- Acrobat Genomics's investors include Taihill Venture.